NCT02670382View on ClinicalTrials.gov

Role of Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) on Inflammation and Lipids

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

May 31, 2020

Study Completion Date

October 31, 2020

Conditions
Metabolic Syndrome
Interventions
DIETARY_SUPPLEMENT

EPA

10 week supplementation

DIETARY_SUPPLEMENT

DHA

10 week supplementation

DIETARY_SUPPLEMENT

sunflower oil

4-week lead-in

Trial Locations (1)

02111

Jean Mayer Human Nutrition Research Center on Aging at Tufts University, Boston

All Listed Sponsors
lead

Tufts University

OTHER

NCT02670382 - Role of Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) on Inflammation and Lipids | Biotech Hunter | Biotech Hunter